mofezolac has been researched along with Abnormalities, Drug-Induced in 2 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
Excerpt | Relevance | Reference |
---|---|---|
"Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent." | 1.28 | [Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration]. ( Fuchigami, K; Kodama, R; Matsunaga, K; Otsuka, T; Sameshima, K; Yamakita, O, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Toteno, I | 1 |
Haguro, S | 1 |
Furukawa, S | 1 |
Morinaga, T | 1 |
Morino, K | 1 |
Fujii, S | 1 |
Yamakita, O | 2 |
Fuchigami, K | 1 |
Otsuka, T | 1 |
Sameshima, K | 1 |
Matsunaga, K | 1 |
Kodama, R | 1 |
2 other studies available for mofezolac and Abnormalities, Drug-Induced
Article | Year |
---|---|
[Reproductive and developmental toxicity study of mofezolac (N-22) (2)--Study by oral administration of N-22 during the period of fetal organogenesis in rats].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; | 1990 |
[Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; | 1990 |